DNA sequencing of sodium bisulfite-treated genomic DNA revealed IRF7 promoter hypermethylation in 2 lung cancer cell lines (CRL5810 and CRL5869), which suggests that epigenetic silencing of IRF7 has played a role in the disruption of IFN signaling in these cell lines (Figure 2A). Here, IRF7 is linked to lung carcinoma.